Leonard Saltz, MD
Metastatic colorectal cancer (mCRC) is an area comprised of several unanswered questions, whether it be optimal chemotherapy regimens, use of frontline EGFR-targeted therapy, or the role of tumor sidedness, explains Leonard Saltz, MD.
on Gastrointestinal Cancers, Saltz, a medical oncologist at Memorial Sloan Kettering Cancer Center, highlighted the current go-to therapies and overarching questions for mCRC treatment.
OncLive: Please provide an overview on your presentation on mCRC.
The question of chemotherapy for patients with metastatic CRC remains a complicated one, simply because we have a number of options, all of which have some advantages and disadvantages, so there really isn’t one right answer. It is one of the reasons that, if someone looks at the NCCN guidelines, it really looks like a “smorgasbord” of choices.
... to read the full story